TxCell S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
675.90
13,917.00
9,208.00
3,482.00
4,910.00
Total Accounts Receivable
2,973.90
3,515.00
3,478.00
1,517.00
2,222.00
Inventories
15.70
4.00
17.00
3.00
-
Other Current Assets
226.30
1,065.00
1,078.00
761.00
398.00
Total Current Assets
3,891.80
18,501.00
13,781.00
5,763.00
7,530.00
Net Property, Plant & Equipment
1,277.60
1,404.00
877.00
799.00
1,041.00
Total Investments and Advances
-
-
45.00
89.00
90.00
Long-Term Note Receivable
5.00
5.00
5.00
177.00
164.00
Intangible Assets
-
8.00
5,907.00
5,911.00
5,935.00
Other Assets
43.90
125.00
-
-
-
Total Assets
5,218.40
20,043.00
20,615.00
12,739.00
14,760.00
ST Debt & Current Portion LT Debt
-
-
-
1,587.00
1,881.00
Accounts Payable
408.50
1,120.00
838.00
893.00
-
Income Tax Payable
8.10
19.00
6.00
40.00
24.00
Other Current Liabilities
1,949.90
2,202.00
6,623.00
5,373.00
6,227.00
Total Current Liabilities
2,366.40
3,341.00
7,467.00
7,893.00
8,132.00
Long-Term Debt
-
1,627.00
1,641.00
3,701.00
1,482.00
Other Liabilities
655.30
363.00
23.00
8.00
-
Total Liabilities
3,021.80
5,331.00
9,131.00
11,602.00
9,614.00
Common Equity (Total)
2,196.60
14,712.00
11,484.00
1,137.00
5,146.00
Total Shareholders' Equity
2,196.60
14,712.00
11,484.00
1,137.00
5,146.00
Total Equity
2,196.60
14,712.00
11,484.00
1,137.00
5,146.00
Liabilities & Shareholders' Equity
5,218.40
20,043.00
20,615.00
12,739.00
14,760.00

About TxCell

View Profile
Address
Les Cardoulines HT1
Valbonne-Sophia Antipolis Rhone-Alpes 06560
France
Employees -
Website http://www.txcell.com/index.php/fr
Updated 09/14/2018
TxCell SA is a biotechnology company. The company engages in the research and development of cellular immunotherapy for chronic inflammatory and autoimmune diseases. Its pipeline consists of Ovasave, col treg, lupus, transplantation and car treg dermatology.